Research

The study was designed to create a global network that enables uro-oncologists to share and discuss their experiences with immunotherapy and other emerging drugs for patients with genitourinary cancers.

Focus Areas

We support diverse research areas, ranging from prevention to the most innovative therapies, and from the study of biological tumor mechanisms to patients' quality of life.

Clinical Studies

Laboratory research

Imaging

Global access to care

Lifestyles

The role of nano- and microplastics

We invest in basic research, which is fundamental for studying the cellular and genetic mechanisms leading to cancer onset, and in translational research, which turns laboratory discoveries into concrete clinical applications. Furthermore, we support clinical research, essential for testing new drugs, therapeutic protocols, and more effective, less invasive treatment strategies.

50+

Scientific Publications

ARON has already generated more than 20 scientific publications in international journals, making a tangible contribution to the advancement of research in the field of uro-oncology.

450+

Co-authors

More than 581 specialists from around the world have chosen to collaborate with ARON, sharing data, clinical experiences, and a commitment to open and collaborative research.

69

Countries

The ARON network currently spans 38 countries, united by a shared vision: to improve patient care through scientific dialogue and international cooperation.

Foundation Activities